Bone Marrow Genetic Studies for Malignant Lymphoma Staging
Optimizing Laboratory Testing for Hematologic Disorders Series
Click CC to turn on closed captioning.
Dr. Kurtin presents the third in our series “Optimizing Laboratory Testing for Hematologic Disorders.” The series addresses guidelines for appropriate laboratory test utilization in hematologic disorders. This presentation will discuss the appropriate utilization of genetic testing when evaluating the bone marrow for involvement by malignant lymphomas.
- Paul J. Kurtin, MD
- Consultant in the Division of Hematopathology, Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota
- 5434 Hematopathology Consultation
- 5439 Surgical Pathology Consultation
- LCMS/3287 Leukemia/Lymphoma Immunophenotyping by Flow Cytometry
- BM/8506 Chromosome Analysis, Hematologic Disorders, Bone Marrow
- TCGBM/31139 T-Cell Receptor Gene Rearrangement, PCR, Bone Marrow
- FBLP/88897 B-Cell Lymphoma, FISH, Blood or Bone Marrow
- FRTLP/89040 T-Cell Lymphoma, FISH, Blood or Bone Marrow
Hematologic Disorders Series
- Hot Topic: Leukocyte Alkaline Phosphatase Stain (LAP) - Optimizing Laboratory Testing for Hematologic Disorders Series
- Hot Topic: Classic Myeloproliferative Neoplasms
- Hot Topic: Bone Marrow Genetic Studies for Malignant Lymphoma Staging
Forward to a Colleague
Share this presentation with:
- Hematology Oncologists
- Laboratory Managers
If you have questions, e-mail .